Recent studies have revealed potential anti-cancer activity of TSN in diverse cancer models, such as glioblastoma, Ewing’s sarcoma, gastric cancer and hepatocellular carcinoma [29, 31–34]. This evidence concerns the gene TSN and Ewing sarcoma.